Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U0CV
|
||||
| Former ID |
DNC014029
|
||||
| Drug Name |
Dodecane-1-sulfonyl fluoride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529659] | ||
| Formula |
C12H25FO2S
|
||||
| Canonical SMILES |
CCCCCCCCCCCCS(=O)(=O)F
|
||||
| InChI |
1S/C12H25FO2S/c1-2-3-4-5-6-7-8-9-10-11-12-16(13,14)15/h2-12H2,1H3
|
||||
| InChIKey |
UVLRFDMRDPQRSM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529659] | |
| Cannabinoid receptor 1 | Target Info | Inhibitor | [529659] | ||
| BioCyc Pathway | Anandamide degradation | ||||
| PANTHER Pathway | Anandamide degradationP05730:Endogenous cannabinoid signaling | ||||
| Pathway Interaction Database | N-cadherin signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.